Igniting Discovery: Contraline and the Future of Reversible Male Contraception

[madman]

In this episode of AUANews Inside Tract, Igniting Discovery, Kevin Eisenfrats, CEO of Contraline and 2025 Innovation Nexus Showcase winner, discusses the development of two novel male contraceptives, a daily hormonal gel (NEST) and a long-lasting, reversible implant (ADAM). He shares insights on clinical progress, regulatory strategy, and advice for innovators navigating the urology startup space through the AUA Innovation Nexus program.

 

[madman]

Thread 'Scientific Advances in Male Contraception'

Aug 27, 2022

Co-presented by Male Contraceptive Initiative and International Consortium on Male Contraception. Moderated by Heather Vahdat, Executive Director, MCI, and Dr. Regine Sitruk-Ware Population Council & ICMC. Panelists: Diana Blithe, Ph.D., Christina Wang, MD, Logan Nickels, Ph.D.

• madman
• concatreptive gel; transdermal; fertility; nes-t
• Replies: 16
• Forum: Testosterone and Men's Health Articles